Kenneth James Livak

Dana-Farber Cancer Inst

$2,617,128

Attributed

$2,617,128

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $590.8K · FY2019–25

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$2,617,128 · 4

By mechanism

P01$2,617,128 · 4

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Inst

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Immunologics”

Bambra Strokes · Ppd Development Lp$526,656,217
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Kevin Urdahl · Seattle Children'S Hospital$85,664,942
Yunda Huang · Fred Hutchinson Cancer Center$71,262,090
Ted Ross · University Of Georgia$68,763,143
Sarah Fortune · Harvard School Of Public Health$51,119,645

Research focus

ImmunologicsMinor Histocompatibility AntigensImmuneImmunogenomicsInsightLaboratoriesApplications GrantsDna SequencingDna AnalysisImmunogenicityAntigensExome SequencingCell LineCell PhysiologyCellsCharacteristicsAlpha-Beta T-Cell ReceptorData AnalysesBeta Chain Antigen T Cell ReceptorAlgorithmsBindingImmune ResponseComputerized ToolsPathway Interactions